[go: up one dir, main page]

SK285338B6 - Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy - Google Patents

Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy Download PDF

Info

Publication number
SK285338B6
SK285338B6 SK293-2001A SK2932001A SK285338B6 SK 285338 B6 SK285338 B6 SK 285338B6 SK 2932001 A SK2932001 A SK 2932001A SK 285338 B6 SK285338 B6 SK 285338B6
Authority
SK
Slovakia
Prior art keywords
ibuprofen
cyclodextrin
mixing
sodium
pharmaceutical composition
Prior art date
Application number
SK293-2001A
Other languages
English (en)
Slovak (sk)
Other versions
SK2932001A3 (en
Inventor
P�Rez Mar�A Teresa Tarr�
Casas Montserrat Trullols
Faus Xavier Font
Original Assignee
Laboratorio De Aplicaciones Farmacodinamicas, S. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio De Aplicaciones Farmacodinamicas, S. A. filed Critical Laboratorio De Aplicaciones Farmacodinamicas, S. A.
Publication of SK2932001A3 publication Critical patent/SK2932001A3/sk
Publication of SK285338B6 publication Critical patent/SK285338B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
SK293-2001A 2000-03-03 2001-03-01 Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy SK285338B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000522A ES2171110B1 (es) 2000-03-03 2000-03-03 Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.

Publications (2)

Publication Number Publication Date
SK2932001A3 SK2932001A3 (en) 2001-12-03
SK285338B6 true SK285338B6 (sk) 2006-11-03

Family

ID=8492565

Family Applications (1)

Application Number Title Priority Date Filing Date
SK293-2001A SK285338B6 (sk) 2000-03-03 2001-03-01 Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy

Country Status (8)

Country Link
EP (1) EP1129709B1 (es)
AT (1) ATE298567T1 (es)
CZ (1) CZ301553B6 (es)
DE (1) DE60111657T2 (es)
DK (1) DK1129709T3 (es)
ES (1) ES2171110B1 (es)
PT (1) PT1129709E (es)
SK (1) SK285338B6 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
BRPI0618273A2 (pt) * 2005-11-02 2011-08-23 Teikoku Pharma Usa Inc formulações de dosagem oral de ibuprofeno organolepticamente aceitáveis, métodos de produção e uso das mesmas
EP1840188B1 (en) 2006-03-31 2011-09-07 Sony Deutschland GmbH A composition comprising at least one type of liquid crystal
ES2303468B1 (es) * 2007-01-22 2009-06-08 Masterfarm, S.L "una composicion farmaceutica pulverulenta que comprende ibuprofeno".
EP1974751A1 (en) * 2007-03-26 2008-10-01 The Jordanian Pharmaceutical Manufacturing Co. Formulations for non-steroidal anti-inflammatory drugs
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
JP5977672B2 (ja) * 2009-04-27 2016-08-24 ラボラトリオ デ アプリカシオネス ファルマコディナミカス,エセ.アー.Laboratorio De Aplicaciones Farmacodinamicas,S.A. イブプロフェンリシナートの経口投与用の懸濁液
HUE029953T2 (en) 2009-04-27 2017-04-28 Laboratorio De Aplicaciones Farm S A Ibuprofen lysinate oral suspension
WO2014194872A1 (en) 2013-06-04 2014-12-11 Zentiva, K.S. Taste masking of water soluble drugs using poloxamers
AU2024281739A1 (en) 2023-06-02 2025-11-27 Ioulia Tseti Pharmaceutical composition comprising ibuprofen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (it) * 1990-07-13 1994-06-10 Farcon Ag Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria
DE4038314A1 (de) * 1990-11-30 1992-06-04 Puetter Medice Chem Pharm Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition

Also Published As

Publication number Publication date
PT1129709E (pt) 2005-10-31
CZ2001714A3 (cs) 2001-10-17
DK1129709T3 (da) 2005-10-24
ATE298567T1 (de) 2005-07-15
EP1129709A3 (en) 2001-11-14
DE60111657D1 (de) 2005-08-04
EP1129709B1 (en) 2005-06-29
ES2171110A1 (es) 2002-08-16
CZ301553B6 (cs) 2010-04-14
SK2932001A3 (en) 2001-12-03
DE60111657T2 (de) 2006-05-04
ES2171110B1 (es) 2003-06-16
EP1129709A2 (en) 2001-09-05

Similar Documents

Publication Publication Date Title
DE69902046T2 (de) Neue feste dosisform enthaltend nanopartikelnaproxen
JPH02164820A (ja) イブプロフェン風味マスク法
DE69520768T2 (de) Pharmazeutische Zubereitungen, die Fluoxetin enthalten
US5211958A (en) Pharmaceutical composition and process for its preparation
JP3010562B2 (ja) 徐放性調剤単位
JP2003528931A (ja) 安定な甲状腺ホルモン製剤およびその製法
US7067154B1 (en) Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use
DE20218068U1 (de) Arzneimittel
BE1000168A3 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et du sorbitol.
SK285338B6 (sk) Farmaceutický prípravok na báze ibuprofénu a spôsob jeho prípravy
DE10003757A1 (de) Ibuprofen-Wirkstoffzubereitung
JP2022031345A (ja) St-246(テコビリマット一水和物)懸濁製剤
DE69709349T2 (de) Arzneimittel bestehend aus diclofenac
CN104254249B (zh) 帕唑帕尼制剂
DE60306747T2 (de) Perindopril enthaltende pharmazeutische zusammensetzung mit oraler dispersion
DE60103276T2 (de) Eine stabile pharmazeutische formulierung die torsemid modifikation ii enthält
JP2008509195A (ja) ドロスピレノンとエチニルエストラジオールを含有する薬学的組成物
EP2255810A1 (de) Arzneiformen mit kontrollierter Bioverfügbarkeit, die Vardenafil enthalten
JP2007131561A (ja) 経口固形製剤及びその製造法
EP2726063A1 (en) Ibuprofen chewable tablet
FI89455B (fi) Foerfarande foer framstaellning av en farmaceutisk komposition
JP2001294524A (ja) アセトアミノフェン配合内服固形製剤
JP2015221806A (ja) ヒトの血小板レベルを増加させるための組成物および方法
EP0599767A1 (en) Process to prepare water-dispersable tablets containing diclofenac
JP3995202B2 (ja) 経口用ウコン類組成物

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160301